Efficacy and safety of sildenafil citrate in hemodialysis patients

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 56-58

  Sahin Y ^a   Aygun C ^a,b   Peskircioglu C L ^a   Kut A ^a   Tekin, M I ^a   Ozdemir F N ^a   Ozkardes H ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Department of Nephrology ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; ANGINA PECTORIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; FLUSHING; HEART PALPITATION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NAUSEA; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SEXUALITY;

EID: 0842324836     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.043     Document Type: Conference Paper

References (18)

1. JAMA. 270:1993;83.
2. Montague D.K., Barada J.H., Belker A.M., et al. Clinical guidelines panel on erectile dysfunction summary report on the treatment of organic erectile dysfunction . J Urol. 156:1996;2007.
3. Procci W.R., Goldstein D.A., Adelstein J., et al. Sexual dysfunction in the male patient with uremia a reappraisal . Kidney Int. 19:1981;317.
4. Abraham H.S., Hester L.R., Sheridan W.F., et al. Sexual functioning in patients with chronic renal failure. J Nerv Ment Dis. 160:1975;220.
5. Benet A.E., Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 22:1995;699.
6. Rojfer J., Aronson W.S., Bush P.A., et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 326:1992;90.
7. Boolell M., Gepi-Attee S., Gingell J.C., et al. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol. 78:1996;257.
8. Carson C.C., Patel M.P. The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients. Adv Ren Replace Ther. 6:1999;296.
9. Palmer B.F. Sexual dysfunction in uremia. J Am Soc Nephrol. 10:1999;1381.
10. Massry S.G., Smogorzewski M.J., Klar S. Sexual dysfunction and abnormalities in the hormones of the hypothalamic-pituitary-gonodal axis. Schreier R.W., Gottschalk C.W. Diseases of the kidney, 6th ed, vol 3. 1997;2674 Little, Brown and Company, Boston.
11. Goldstein I., Lue T.F., Padma-Nothan H., et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397.
12. Smith D., Defromo R.A. Endocrine dysfunction in chronic renal failure. Nissenson A.R., Fine R.N., Gentile D.E. Clinical Dialysis, 2nd ed. 1990;476 Appelton & Lange, East Norwalk, Conn.
13. Ermolenko V.M., Kukhtevich A.V., Detoc I.I., et al. Parlodel treatment in uremic hypogonadism in men. Nephron. 42:1986;19.
14. Barton C.H., Mirahmandi M.K., Vaziri N.D. Effects of long term testosteron administration on pituitary-testicular axis in and stage renal failure. Nephron. 31:1982;61.
15. Rosas S.E., Wasserstein A., Kobrin S., et al. Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients. Am J Kidney Dis. 37:2001;134.
16. Türk S., Karalezli G., Tonbul H.Z., et al. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 16:2001;1818.
17. Chen J., Mabjeesh N.J., Greenstein A., et al. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol. 165:2001;819.
18. McMahan C.G., Samal R., Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol. 164:2000;1192.